Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Acute Myeloid Leukemia
Sort By
Newest First
Sign in
1 / 1
1 / 1
Leukemia
Astellas Presents Updated Results from Phase 1 Study of Gilteritinib Plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
Astellas
PR-M12-18-NI-025
Dec 07, 2018
Collaboration Agreement
Cilag GmbH to Collaborate with argenx on New Treatment for AML, MDS
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-005
Dec 05, 2018
